ARGX
Price
$536.11
Change
+$11.53 (+2.20%)
Updated
Sep 27 closing price
25 days until earnings call
BBIO
Price
$24.94
Change
+$0.46 (+1.88%)
Updated
Sep 27 closing price
32 days until earnings call
Ad is loading...

ARGX vs BBIO

Header iconARGX vs BBIO Comparison
Open Charts ARGX vs BBIOBanner chart's image
argenx SE
Price$536.11
Change+$11.53 (+2.20%)
Volume$138.45K
CapitalizationN/A
BridgeBio Pharma
Price$24.94
Change+$0.46 (+1.88%)
Volume$1.84M
CapitalizationN/A
View a ticker or compare two or three
ARGX vs BBIO Comparison Chart
Loading...
ARGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARGX vs. BBIO commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGX is a StrongBuy and BBIO is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (ARGX: $514.23 vs. BBIO: $28.74)
Brand notoriety: ARGX and BBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARGX: 46% vs. BBIO: 391%
Market capitalization -- ARGX: $31.99B vs. BBIO: $4.69B
ARGX [@Biotechnology] is valued at $31.99B. BBIO’s [@Biotechnology] market capitalization is $4.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARGX’s FA Score shows that 1 FA rating(s) are green whileBBIO’s FA Score has 1 green FA rating(s).

  • ARGX’s FA Score: 1 green, 4 red.
  • BBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, ARGX is a better buy in the long-term than BBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARGX’s TA Score shows that 3 TA indicator(s) are bullish while BBIO’s TA Score has 3 bullish TA indicator(s).

  • ARGX’s TA Score: 3 bullish, 4 bearish.
  • BBIO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ARGX is a better buy in the short-term than BBIO.

Price Growth

ARGX (@Biotechnology) experienced а -0.47% price change this week, while BBIO (@Biotechnology) price change was +15.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

ARGX is expected to report earnings on Oct 24, 2024.

BBIO is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARGX($32B) has a higher market cap than BBIO($4.69B). ARGX YTD gains are higher at: 35.171 vs. BBIO (-28.809).
ARGXBBIOARGX / BBIO
Capitalization32B4.69B682%
EBITDAN/AN/A-
Gain YTD35.171-28.809-122%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ARGX: Fundamental Ratings
ARGX
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARGXBBIO
RSI
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
Stochastic
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Momentum
ODDS (%)
N/A
Bearish Trend about 1 month ago
0%
MACD
ODDS (%)
Bearish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 2 months ago
0%
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
ARGX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

ARGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with BBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
-0.60%
BBIO - ARGX
46%
Loosely correlated
+3.20%
BLUE - ARGX
45%
Loosely correlated
+1.03%
NRBO - ARGX
43%
Loosely correlated
-4.91%
MNKD - ARGX
33%
Poorly correlated
-2.88%
ABOS - ARGX
32%
Poorly correlated
-10.58%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with BPMC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+3.20%
BPMC - BBIO
52%
Loosely correlated
-3.15%
NTLA - BBIO
51%
Loosely correlated
-3.65%
FOLD - BBIO
47%
Loosely correlated
+0.17%
SNDX - BBIO
46%
Loosely correlated
-0.05%
NAUT - BBIO
46%
Loosely correlated
-2.31%
More